JB Reed/Bloomberg News
Warner Chilcott makes drugs like the birth control pill Estrostep, left, and the acne treatment Doryx.
Warner Chilcott Says It Is in Preliminary Sale Talks
The pharmaceutical company confirms recent market speculation by saying that it is exploring strategic alternatives, including potential offers.
Stuart Isett for The New York Times
Dr. Elizabeth Sanders uses a Hologic digital mammography machine for breast examinations at a clinic in Auburn, Wash.
Hologic Agrees to Buy Gen-Probe for $3.72 Billion
Hologic is buying Gen-Probe, a maker of molecular diagnostics products, in an all-cash deal.
Qilai Shen/Bloomberg News
Guy Hands, chief of Terra Firma.
Terra Firma to Buy Nursing Home Firm for $1.3 Billion
The private equity firm has agreed to buy the British nursing home operator Four Seasons Health Care for up to $1.3 billion.
Johannes Eisele/Reuters
The headquarters of Fresenius in Bad Homburg, Germany.
Fresenius Group Bids $4.1 Billion for Hospital Operator
The Fresenius Group offered $4.1 billion to buy the German hospital operator Rhön-Klinikum, as it looked to increase its presence in the German market.
Bill Gallery/Watson Pharmaceuticals, via Associated Press
A generic version of Lipitor, or atorvastatin, made by Watson Pharmaceuticals.
Watson to Buy Actavis for $5.9 Billion
Watson Pharmaceuticals agreed on Wednesday to buy the Swiss drug maker Actavis Group for up to 4.5 billion euros ($5.9 billion), as the American company looked to expand its presence in overseas markets.
Scott Eells/Bloomberg News
Carl C. Icahn
Amylin and Icahn Make Nice, Sending Shares Up
Carl C. Icahn has withdrawn his lawsuit against Amylin Pharmaceuticals, citing a conversation he had with the drug maker’s chief executive. What exactly was said, however, remains a mystery.
Business Day Live: Apple’s Profit Soars on Sales in China
Using tough tactics to collect medical debts; waiting and watching at the Federal Reserve; and Sam Grobart on Apple Inc., the profit machine.
Amgen to Buy Turkish Drug Maker |
The biotechnology company Amgen agreed on Wednesday to buy 95.6 percent of the privately held Turkish company Mustafa Nevzat Pharmaceuticals for an amount that values the firm at $700 million. The acquisition will help Amgen to expand its operations in the fast-growing Turkish market and the surrounding region. Read more »
Bill Gallery/Watson Pharmaceuticals, via Associated Press
A generic version of Lipitor, or atorvastatin, made by Watson Pharmaceuticals.
Watson Is Said to Bid $5.9 Billion for Actavis
Watson Pharmaceuticals is expected to offer 4.5 billion euros for the Swiss drug maker Actavis Group, in a deal that would create one of the world’s largest generic drug manufacturers.
Thomson Reuters Sells Health Care Business for $1.25 Billion
Adding to a flurry of health care deals announced on Monday, Thomson Reuters has sold its health care unit to an affiliate of Veritas Capital for $1.25 billion in cash.
Saquan Stimpson/The News Journal
An AstraZeneca plant in Newark, Del.
A Hot Time for Health Care Deals
Amid a weak merger market, drug makers are striking a flurry of deals, with Pfizer agreeing to sell its infant nutrition unit to Nestlé for $11.9 billion on Monday.
AstraZeneca, via Reuters
AstraZeneca employees at a plant in Macclesfield, Britain.
AstraZeneca Reaches $1.26 Billion Deal for Ardea Biosciences
The European drug maker AstraZeneca agreed on Monday to buy the biotech company Ardea Biosciences for $1.26 billion, the latest in a recent series of deals in the global pharmaceutical industry.
Amylin Is Said to Pursue a Sale
Amylin is working with Credit Suisse, Goldman Sachs and the law firm Skadden, Arps, Slate, Meagher & Flom, according to a person briefed on the matter, who added that no sale is imminent.
Harry Campbell
The Escalation in Hostile Takeover Offers
Glaxo-Human Genome Sciences, Roche-Illumina, Carl Icahn-CVR Energy: What to make of a flurry of deal activity of late.
Business Day Live: India Struggles With Growth
I.M.F. meeting opens as a European slowdown looms; a lack of energy infrastructure hampers growth in India; and questions about safety of medical devices.
Loading Twitter messages...
Facebook
Twitter
YouTube
RSS